SFS
TGTX icon

Sowell Financial Services’s TG Therapeutics TGTX Stock Holding History

Sowell Financial Services’s Portfolio TGTX Stock Details TGTX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2021
Q2 		– Sell
-625
Closed -$25K – 2494
2021
Q1 		$25K Sell
625
-226
-27% -$10.9K ﹤0.01% 1961
2020
Q4 		$44K Buy
851
+271
+47% +$9.16K ﹤0.01% 1446
2020
Q3 		$16K Sell
580
-1,618
-74% -$37.2K ﹤0.01% 1659
2020
Q2 		$43K Buy
+2,198
New +$35.4K ﹤0.01% 1205
2019
Q4 		– Sell
-50
Closed – – 2656
2019
Q3 		$0 Buy
+50
New +$349 ﹤0.01% 2458

Other funds holding TGTX

Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $846B AUM 46.74% 1-Year Est. Return
Alkeon Capital Management
Alkeon Capital Management New York $74.1B AUM 71.18% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
RCM
RA Capital Management Boston, Massachusetts $11.5B AUM 168.77% 1-Year Est. Return
Lord, Abbett & Co
Lord, Abbett & Co Jersey City, New Jersey $34.9B AUM 72.7% 1-Year Est. Return
MC
Maverick Capital Dallas, Texas $11.3B AUM 76.6% 1-Year Est. Return

Sowell Financial Services's TGTX Position: Q2 2021 in Review

Sowell Financial Services sold out of TG Therapeutics (TGTX) in Q2 2021, closing a stake of 625 shares — an estimated $25K sold.

Sowell Financial Services first reported a position in TGTX in Q3 2019 and held it in 5 quarters. The position peaked at $44K in Q4 2020. 237 funds tracked by Wall St. Rank hold TGTX as of Q2 2021.

  • Sowell Financial Services reported no remaining TG Therapeutics position as of Q2 2021 after selling out during the quarter.
  • Sowell Financial Services sold 625 TG Therapeutics shares in Q2 2021, an estimated $25K.
  • Sowell Financial Services first reported a position in TG Therapeutics in Q3 2019 and held it in 5 quarters.
  • Sowell Financial Services's TG Therapeutics position peaked at $44K in Q4 2020.
  • 237 funds tracked by Wall St. Rank held TG Therapeutics as of Q2 2021.

Based on Sowell Financial Services's 13F filing for Q2 2021, filed 5 Aug 2021.